{"pmid":32348472,"pmcid":"PMC7197587","title":"A Marker of Systemic Inflammation or Direct Cardiac Injury: Should Cardiac Troponin Levels be Monitored in COVID-19 Patients?","text":["A Marker of Systemic Inflammation or Direct Cardiac Injury: Should Cardiac Troponin Levels be Monitored in COVID-19 Patients?","Eur Heart J Qual Care Clin Outcomes","Atallah, Bassam","Mallah, Saad I","AbdelWareth, Laila","AlMahmeed, Wael","Fonarow, Gregg C","32348472"],"journal":"Eur Heart J Qual Care Clin Outcomes","authors":["Atallah, Bassam","Mallah, Saad I","AbdelWareth, Laila","AlMahmeed, Wael","Fonarow, Gregg C"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348472","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1093/ehjqcco/qcaa033","topics":["Treatment","Mechanism","Diagnosis"],"weight":1,"_version_":1666138495433834498,"score":9.490897,"similar":[{"pmid":32382587,"pmcid":"PMC7204698","title":"Cardiac Troponin-I may be a predictor of complications and mortality in COVID-19 patients.","text":["Cardiac Troponin-I may be a predictor of complications and mortality in COVID-19 patients.","Curr Med Res Pract","Paul, Prannoy","32382587"],"journal":"Curr Med Res Pract","authors":["Paul, Prannoy"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32382587","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.cmrp.2020.05.001","keywords":["troponin i","coronavirus"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666419683282124800,"score":66.13585},{"pmid":32499236,"title":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?","text":["COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?","The initial mechanism for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is the binding of the virus to the membrane-bound form of ACE2, which is mainly expressed in the lung. Since the heart and the vessels also express ACE2, they both could become targets of the virus. However, at present the extent and importance of this potential involvement are unknown. Cardiac troponin levels are significantly higher in patients with more severe infections, patients admitted to intensive care units or in those who have died. In the setting of COVID-19, myocardial injury, defined by an increased troponin level, occurs especially due to non-ischaemic myocardial processes, including severe respiratory infection with hypoxia, sepsis, systemic inflammation, pulmonary thrombosis and embolism, cardiac adrenergic hyperstimulation during cytokine storm syndrome, and myocarditis. At present, there are limited reports on definite diagnosis of myocarditis caused by SARS-CoV-2 in humans and limited demonstration of the virus in the myocardium. In conclusion, although the heart and the vessels are potential targets in COVID-19, there is currently limited evidence on the direct infection of the myocardium by SARS-CoV-2. Additional pathological studies and autopsy series will be very helpful to clarify the potentiality of COVID-19 to directly infect the myocardium and cause myocarditis.","Heart","Imazio, Massimo","Klingel, Karin","Kindermann, Ingrid","Brucato, Antonio","De Rosa, Francesco Giuseppe","Adler, Yehuda","De Ferrari, Gaetano Maria","32499236"],"abstract":["The initial mechanism for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is the binding of the virus to the membrane-bound form of ACE2, which is mainly expressed in the lung. Since the heart and the vessels also express ACE2, they both could become targets of the virus. However, at present the extent and importance of this potential involvement are unknown. Cardiac troponin levels are significantly higher in patients with more severe infections, patients admitted to intensive care units or in those who have died. In the setting of COVID-19, myocardial injury, defined by an increased troponin level, occurs especially due to non-ischaemic myocardial processes, including severe respiratory infection with hypoxia, sepsis, systemic inflammation, pulmonary thrombosis and embolism, cardiac adrenergic hyperstimulation during cytokine storm syndrome, and myocarditis. At present, there are limited reports on definite diagnosis of myocarditis caused by SARS-CoV-2 in humans and limited demonstration of the virus in the myocardium. In conclusion, although the heart and the vessels are potential targets in COVID-19, there is currently limited evidence on the direct infection of the myocardium by SARS-CoV-2. Additional pathological studies and autopsy series will be very helpful to clarify the potentiality of COVID-19 to directly infect the myocardium and cause myocarditis."],"journal":"Heart","authors":["Imazio, Massimo","Klingel, Karin","Kindermann, Ingrid","Brucato, Antonio","De Rosa, Francesco Giuseppe","Adler, Yehuda","De Ferrari, Gaetano Maria"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32499236","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1136/heartjnl-2020-317186","keywords":["acute coronary syndromes","myocarditis","pericardial effusion","thromboembolic pulmonary vascular disease"],"locations":["hypoxia","cytokine"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668890966313926657,"score":64.72276},{"pmid":32467423,"title":"Potential mechanisms of cardiac injury and common pathways of inflammation in patients with COVID-19.","text":["Potential mechanisms of cardiac injury and common pathways of inflammation in patients with COVID-19.","Due to the lack of prospective, randomized, controlled clinical studies on inflammation and cardiovascular involvement, the exact mechanism of cardiac injury among patients with COVID-19 still remains uncertain. It was demonstrated that there is a high and significantly positive linear correlation between troponin T and plasma high-sensitivity C-reactive protein levels, biomarkers of cardiac injury and systemic inflammation, respectively. Cardiac injury and inflammation is a relatively common association among patients hospitalized with COVID-19, and it is related to higher risk of in-hospital mortality. In our literature search, we identified several potential mechanisms of myocardial tissue damage, namely, coronavirus-associated acute myocarditis, angiotensin-converting enzyme 2 receptor binding affinity to the virus Spike protein, increased cytokine secretion, and hypoxia induced cardiac myocyte apoptosis. Elucidation of the disease pathogenesis and prospective histopathological studies are crucial for future proper treatment in case of renewed outbreaks. Of interest is that with hundred of thousands of bodies available for autopsy studies, no prospective investigation has been reported so far. Strong efforts and continued research of the cardiovascular complications and identification of risk factors for poor prognosis in COVID-19 are steadily needed. The high morbidity and mortality of COVID-19, its monumental economic burden and social impact, the despair of a new pandemic outbreak, and the thread of potential utilization of novel SARS-CoV2 as biologic weapons make it a preponderant necessity to better comprehend the therapeutic management of this lethal disease. Emerging as an acute infectious disease, COVID-19 may become a chronic epidemic because of genetic recombination. Therefore, we should be ready for the reemergence of COVID-19 or other coronaviruses.","Crit Pathw Cardiol","Centurion, Osmar Antonio","Scavenius, Karina E","Garcia, Laura B","Torales, Judith M","Mino, Luis M","32467423"],"abstract":["Due to the lack of prospective, randomized, controlled clinical studies on inflammation and cardiovascular involvement, the exact mechanism of cardiac injury among patients with COVID-19 still remains uncertain. It was demonstrated that there is a high and significantly positive linear correlation between troponin T and plasma high-sensitivity C-reactive protein levels, biomarkers of cardiac injury and systemic inflammation, respectively. Cardiac injury and inflammation is a relatively common association among patients hospitalized with COVID-19, and it is related to higher risk of in-hospital mortality. In our literature search, we identified several potential mechanisms of myocardial tissue damage, namely, coronavirus-associated acute myocarditis, angiotensin-converting enzyme 2 receptor binding affinity to the virus Spike protein, increased cytokine secretion, and hypoxia induced cardiac myocyte apoptosis. Elucidation of the disease pathogenesis and prospective histopathological studies are crucial for future proper treatment in case of renewed outbreaks. Of interest is that with hundred of thousands of bodies available for autopsy studies, no prospective investigation has been reported so far. Strong efforts and continued research of the cardiovascular complications and identification of risk factors for poor prognosis in COVID-19 are steadily needed. The high morbidity and mortality of COVID-19, its monumental economic burden and social impact, the despair of a new pandemic outbreak, and the thread of potential utilization of novel SARS-CoV2 as biologic weapons make it a preponderant necessity to better comprehend the therapeutic management of this lethal disease. Emerging as an acute infectious disease, COVID-19 may become a chronic epidemic because of genetic recombination. Therefore, we should be ready for the reemergence of COVID-19 or other coronaviruses."],"journal":"Crit Pathw Cardiol","authors":["Centurion, Osmar Antonio","Scavenius, Karina E","Garcia, Laura B","Torales, Judith M","Mino, Luis M"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32467423","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1097/HPC.0000000000000227","topics":["Treatment","Mechanism"],"weight":1,"_version_":1668420887169204224,"score":64.175385},{"pmid":32255359,"title":"Clinical utility of cardiac troponin measurement in COVID-19 infection.","text":["Clinical utility of cardiac troponin measurement in COVID-19 infection.","Ann Clin Biochem","Gaze, David C","32255359"],"journal":"Ann Clin Biochem","authors":["Gaze, David C"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32255359","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1177/0004563220921888","keywords":["covid-19","sars-cov-2","troponin","analytes","cardiac troponin i","cardiac troponin t"],"topics":["Transmission","Diagnosis","Treatment"],"weight":1,"_version_":1666138493136404481,"score":63.861885},{"pmid":32484975,"title":"Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis.","text":["Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis.","Elevation of high-sensitivity cardiac troponin (hs-cTn) is a surrogate of myocardial injury, which appears to be a common complication of coronavirus disease 2019 (COVID-19). In this study, a meta-analysis was performed to clarify the association between myocardial injury assessed by hs-cTn levels and in-hospital mortality in patients with COVID-19. All existing studies on myocardial injury in patients with COVID-19 were retrieved from PubMed and EMBASE through April 13, 2020. In cases where overlap of the study population or enrollment period was found in articles published from the same hospitals, the article with the largest number of patients was only included in the analysis. The pooled odds ratio was calculated using inverse variance weighted random-effects models. Six observational studies which included a total of 1,231 patients met the search criteria. The percentage of patients with hs-cTn levels varied across the studies (13-41%). Elevated hs-cTn levels were significantly associated with an increase in in-hospital mortality (pooled odds ratio, 22.7; 95% confidence interval, 13.6-38.1; P<0.001) with a moderate heterogeneity (I(2) =28%), suggesting that elevated hs-cTn levels might be used as a reliable marker of disease severity early in the course of COVID-19. This article is protected by copyright. All rights reserved.","J Med Virol","Aikawa, Tadao","Takagi, Hisato","Ishikawa, Kiyotake","Kuno, Toshiki","32484975"],"abstract":["Elevation of high-sensitivity cardiac troponin (hs-cTn) is a surrogate of myocardial injury, which appears to be a common complication of coronavirus disease 2019 (COVID-19). In this study, a meta-analysis was performed to clarify the association between myocardial injury assessed by hs-cTn levels and in-hospital mortality in patients with COVID-19. All existing studies on myocardial injury in patients with COVID-19 were retrieved from PubMed and EMBASE through April 13, 2020. In cases where overlap of the study population or enrollment period was found in articles published from the same hospitals, the article with the largest number of patients was only included in the analysis. The pooled odds ratio was calculated using inverse variance weighted random-effects models. Six observational studies which included a total of 1,231 patients met the search criteria. The percentage of patients with hs-cTn levels varied across the studies (13-41%). Elevated hs-cTn levels were significantly associated with an increase in in-hospital mortality (pooled odds ratio, 22.7; 95% confidence interval, 13.6-38.1; P<0.001) with a moderate heterogeneity (I(2) =28%), suggesting that elevated hs-cTn levels might be used as a reliable marker of disease severity early in the course of COVID-19. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Aikawa, Tadao","Takagi, Hisato","Ishikawa, Kiyotake","Kuno, Toshiki"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32484975","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jmv.26108","keywords":["covid-19","coronavirus disease 2019","high-sensitivity cardiac troponin","in-hospital mortality","meta-analysis","myocardial injury"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1668532114837995521,"score":61.894566}]}